Total Payments
$15,339
2024 Payments
$699.69
Companies
26
Transactions
177
Medicare Patients
10,448
Medicare Billing
$648,508
Payment Breakdown by Category
Other$7,807 (50.9%)
Food & Beverage$6,111 (39.8%)
Travel$1,421 (9.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $7,458 | 4 | 48.6% |
| Food and Beverage | $6,111 | 166 | 39.8% |
| Travel and Lodging | $1,421 | 6 | 9.3% |
| Grant | $349.00 | 1 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Aziyo Biologics, Inc. | $9,767 | 19 | $0 (2023) |
| Abbott Laboratories | $3,024 | 65 | $0 (2024) |
| Medtronic, Inc. | $671.29 | 9 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $475.58 | 23 | $0 (2024) |
| PFIZER INC. | $179.31 | 10 | $0 (2024) |
| Impulse Dynamics (USA) Inc. | $179.18 | 3 | $0 (2023) |
| Edwards Lifesciences Corporation | $146.82 | 2 | $0 (2022) |
| ABIOMED | $108.54 | 2 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $86.99 | 6 | $0 (2023) |
| Amgen Inc. | $86.84 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $699.69 | 28 | Abbott Laboratories ($241.45) |
| 2023 | $1,563 | 40 | Medtronic, Inc. ($563.66) |
| 2022 | $885.09 | 31 | Abbott Laboratories ($295.59) |
| 2021 | $8,422 | 31 | Aziyo Biologics, Inc. ($7,069) |
| 2020 | $535.61 | 15 | Abbott Laboratories ($490.49) |
| 2019 | $1,409 | 10 | Aziyo Biologics, Inc. ($1,152) |
| 2018 | $229.47 | 9 | Abbott Laboratories ($140.18) |
| 2017 | $1,595 | 13 | Aziyo Biologics, Inc. ($1,000) |
All Payment Transactions
177 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Abbott Laboratories | ACCENT (Device) | Food and Beverage | In-kind items and services | $132.52 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/17/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $10.62 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/17/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $5.95 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/21/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.36 | General |
| Category: Cardiovascular | ||||||
| 10/15/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $93.24 | General |
| Category: Cardiovascular | ||||||
| 10/11/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: CARDIAC RHYTHM MANAGEMENT | ||||||
| 10/02/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.65 | General |
| Category: Cardiovascular | ||||||
| 10/02/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.92 | General |
| Category: Cardiovascular | ||||||
| 08/29/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $12.73 | General |
| Category: Cardiovascular | ||||||
| 08/26/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $6.77 | General |
| Category: Cardiac Rhythm Management | ||||||
| 08/22/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $21.48 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/20/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.91 | General |
| Category: Cardiovascular | ||||||
| 08/05/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/02/2024 | Medtronic, Inc. | ANTERALIGN SPINAL SYSTEM WITH TITAN NANOLOCK SURFACE TECHNOLOGY (Device) | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: TL | ||||||
| 06/18/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/14/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Not Applicable | ||||||
| 05/15/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.32 | General |
| Category: Cardiovascular | ||||||
| 05/14/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $7.71 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/24/2024 | Abbott Laboratories | ASSURITY (Device) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Cardiac Rhythm Management | ||||||
| 04/12/2024 | Abbott Laboratories | ASSURITY (Device) | Food and Beverage | In-kind items and services | $25.71 | General |
| Category: Cardiac Rhythm Management | ||||||
| 03/26/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.62 | General |
| Category: Cardiovascular | ||||||
| 03/19/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Not Applicable | ||||||
| 03/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Cardiology | ||||||
| 03/14/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: Cardiac Rhythm Management | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 35 | 2,669 | 3,197 | $575,348 | $164,095 |
| 2022 | 30 | 3,424 | 4,724 | $730,702 | $199,829 |
| 2021 | 24 | 1,801 | 2,651 | $370,355 | $94,686 |
| 2020 | 28 | 2,554 | 4,334 | $982,443 | $189,898 |
Total Patients
10,448
Total Services
14,906
Medicare Billing
$648,508
Procedure Codes
123
All Medicare Procedures & Services
123 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 475 | 479 | $103,464 | $25,308 | 24.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 182 | 187 | $81,345 | $25,221 | 31.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 221 | 264 | $59,400 | $23,679 | 39.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 242 | 246 | $37,638 | $14,412 | 38.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 119 | 178 | $27,234 | $10,988 | 40.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 60 | 60 | $21,480 | $7,377 | 34.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 61 | 61 | $18,300 | $6,208 | 33.9% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 67 | 101 | $20,503 | $5,700 | 27.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 457 | 565 | $37,855 | $5,394 | 14.2% |
| 93307 | Ultrasound of heart | Office | 2023 | 59 | 59 | $24,402 | $5,098 | 20.9% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 13 | 13 | $27,261 | $5,063 | 18.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 26 | 26 | $19,474 | $3,940 | 20.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 24 | $7,272 | $3,071 | 42.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 51 | 58 | $4,988 | $2,337 | 46.8% |
| 93285 | Programming of cardiac rhythm monitor system | Office | 2023 | 14 | 46 | $6,578 | $2,170 | 33.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $5,759 | $2,145 | 37.2% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 48 | 75 | $8,625 | $1,740 | 20.2% |
| 93291 | Evaluation of cardiac rhythm monitor system | Office | 2023 | 12 | 43 | $5,332 | $1,657 | 31.1% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 13 | 20 | $6,120 | $1,569 | 25.6% |
| 93279 | Programming of single lead pacemaker system | Office | 2023 | 22 | 31 | $5,363 | $1,536 | 28.6% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 46 | 64 | $6,848 | $1,097 | 16.0% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 64 | 64 | $4,672 | $1,062 | 22.7% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 20 | 46 | $4,232 | $899.56 | 21.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 104 | 128 | $3,840 | $825.50 | 21.5% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 14 | 31 | $5,239 | $800.80 | 15.3% |
About Dr. David Woodard, M.D
Dr. David Woodard, M.D is a Cardiovascular Disease healthcare provider based in Pensacola, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1598736670.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Woodard, M.D has received a total of $15,339 in payments from pharmaceutical and medical device companies, with $699.69 received in 2024. These payments were reported across 177 transactions from 26 companies. The most common payment nature is "Honoraria" ($7,458).
As a Medicare-enrolled provider, Woodard has provided services to 10,448 Medicare beneficiaries, totaling 14,906 services with total Medicare billing of $648,508. Data is available for 4 years (2020–2023), covering 123 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Clinical Cardiac Electrophysiology, Clinical Cardiac Electrophysiology
- Location Pensacola, FL
- Active Since 01/27/2006
- Last Updated 04/14/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1598736670
Products in Payments
- ECM Patch,Pouch (Device) $8,696
- ECM Patch (Device) $1,000
- MICRA (Device) $563.66
- Allure Quadra RF CRT Pacemaker (Device) $533.42
- Assurity Pacemaker (Device) $477.05
- ELIQUIS (Drug) $453.74
- Quadra Allure MP RF CRT Pacemkr (Device) $355.25
- Fortify Assura, Ellipse ICD (Device) $220.46
- OPTIMIZER (Device) $179.18
- CAMZYOS (Drug) $159.79
- Confirm Rx (Device) $156.84
- AVEIR (Device) $151.18
- Cardiac Mapping System (Device) $132.75
- ACCENT (Device) $132.52
- Quadra Assura CRT Defibrillator (Device) $117.98
- ICDs (Device) $114.86
- Impella (Device) $108.54
- Ablation Therapy Hardware (Device) $106.49
- ALLURE QUADRA (Device) $92.11
- Repatha (Biological) $86.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Pensacola
Rohit Amin, Md, MD
Cardiovascular Disease — Payments: $762,056
Cardiovascular Disease $762,056
Franklin Fleischhauer, Md, MD
Cardiovascular Disease — Payments: $165,601
Cardiovascular Disease $165,601
Mark Grise, Md, MD
Cardiovascular Disease — Payments: $86,692
Cardiovascular Disease $86,692
Sergey Kachur, M.d, M.D
Cardiovascular Disease — Payments: $35,457
Cardiovascular Disease $35,457
Dr. Marcelo Branco, Md, MD
Cardiovascular Disease — Payments: $13,222
Cardiovascular Disease $13,222
Licheng Lee, M.d, M.D
Cardiovascular Disease — Payments: $8,409
Cardiovascular Disease $8,409